Detalhe da pesquisa
1.
MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death.
Mol Cell
; 66(5): 698-710.e5, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28506461
2.
Protein kinase C phosphorylates AMP-activated protein kinase α1 Ser487.
Biochem J
; 473(24): 4681-4697, 2016 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27784766
3.
Preclinical Characterization of AZD9574, a Blood-Brain Barrier Penetrant Inhibitor of PARP1.
Clin Cancer Res
; 30(7): 1338-1351, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37967136
4.
Drug-gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition.
Cancer Res Commun
; 2(10): 1244-1254, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36969741
5.
Preclinical Characterization of AZD5305, A Next-Generation, Highly Selective PARP1 Inhibitor and Trapper.
Clin Cancer Res
; 28(21): 4724-4736, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35929986
6.
Primidone blocks RIPK1-driven cell death and inflammation.
Cell Death Differ
; 28(5): 1610-1626, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33273695
7.
RIPK1-mediated immunogenic cell death promotes anti-tumour immunity against soft-tissue sarcoma.
EMBO Mol Med
; 12(6): e10979, 2020 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32419365
8.
Mind Bomb Regulates Cell Death during TNF Signaling by Suppressing RIPK1's Cytotoxic Potential.
Cell Rep
; 23(2): 470-484, 2018 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29642005